Global Pharmacy Benefit Management Market to Grow at 4.77% During 2025-2033, Fueled by Rising Pharmaceutical Expenditure

January 14, 2025 | Healthcare

According to the latest report by IMARC Group, titled “Pharmacy Benefit Management Market Report by Service (Specialty Pharmacy Services, Drug Formulary Management, Retail Pharmacy Services, Benefit Plan Design and Consultation, Disease Management Services, and Others), Business Model (Health Insurance Management, Standalone PBMs, Retail Pharmacy), End Use (Federal, Commercial), and Region 2025-2033,” the global pharmacy benefit management market size reached USD 603.0 Billion in 2024. Pharmacy Benefit Management (PBM) refers to an organization of prescription drug programs that administer, monitor, and handle issues related to drug development, formulas, contracts, and claims and provides prescription drug benefits. It is a third-party administrator that acts as an intermediary between insurance companies, drug manufacturers, and pharmacies, providing employers with medical services and prescription medications at reduced costs. The cost reduction is achieved through negotiating with drug manufacturers for discounts on drug prices and reimbursements from collaborating with pharmacies, processing and compensating prescription drug claims, and working with self-insured companies and government programs. Apart from this, PBM companies conduct generic drug substitution and participate in drug formulary development and management. As a result, they are extensively used for numerous services in specialty pharmacies, retail pharmacies, and drug formularies or disease management, amongst others.


Global Pharmacy Benefit Management Market Trends:

The widespread prevalence of chronic diseases, such as cardiovascular disorders (CVDs) and lung infections, is primarily driving the market growth. Such occurrences have fueled the demand for expensive branded medications across the globe, resulting in a significant increase in pharmaceutical spending, creating a need for cost management of prescription drugs. Besides this, drug price inflations are propelling the demand for PBM among health insurance providers, further presenting remunerative opportunities for the market’s growth. In addition to this, the easy availability of similar drugs in the market with minimal differences in their active pharmaceutical ingredient (API) has heightened the price sensitivity of these drugs, which is contributing to the market growth. Moreover, the integration of machine learning (ML) and artificial intelligence (AI) technologies to improve workflow by streamlining the supply chain, achieving faster order delivery, and catering to many insurance and retail pharmacy chains within a limited time is aiding in market expansion. Furthermore, the shifting preference for PBM systems for better expertise and connections with pharmaceutical companies, establishing drug contracts, and gaining access to medicines across various retail pharmacy networks are positively influencing the market growth. Looking forward, the market value is projected to reach USD 950.7 Billion by 2033, expanding at a CAGR of 4.77% during 2025-2033.


Market Summary:

  • Based on the service, the market is categorized into specialty pharmacy services, drug formulary management, retail pharmacy services, benefit plan design and consultation, disease management services, and others.
  • On the basis of the business model, the market is segregated into health insurance management, standalone PBMs, and retail pharmacy.
  • Based on the end use, the market has been bifurcated into federal and commercial.
  • Region-wise, the market has been segmented into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, and others), Asia-Pacific (China, Japan, India, Australia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa (Saudi Arabia, South Africa, United Arab Emirates, and Others).
  • The competitive landscape of the market has also been examined, with some of the key players being Aetna, Inc., Centene Corporation, Cigna Corporation, CVS Health Corporation, Express Scripts Holding Company, Magellan Health, Inc., Medimpact Healthcare Systems, Inc., Optumrx, Inc., Prime Therapeutics LLC, ProCare Rx, and SS&c Technologies, Inc.
     

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Service, Business Model, End Use, Region
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, United Arab Emirates
Companies Covered Aetna, Inc., Centene Corporation, Cigna Corporation, CVS Health Corporation, Express Scripts Holding Company, Magellan Health, Inc., Medimpact Healthcare Systems, Inc., Optumrx, Inc., Prime Therapeutics LLC, ProCare Rx, and SS&c Technologies, Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Pharmacy Benefit Management Market to Grow at 4.77% During 2025-2033, Fueled by Rising Pharmaceutical Expenditure
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials